hi we got a mention in the SMH
cheers
10.06am
Mesoblast in halt as investors hold breath for news
By Emma Koehn
Investors in stem cell hopeful Mesoblast have been refreshing their screens for the past 12 hours, waiting for news on whether the company’s flagship product, Ryoncil, would be approved by the US Food and Drug Administration.
Mesoblast shares entered a trading halt on the New York Stock Exchange yesterday and the company announced just before the market open that they were entering a halt on the ASX too. The FDA had set an “action date” of September 30 to make a final call on whether the company’s treatment for steroid-refractory graft-versus-host disease would be approved for use.
Mesoblast is in a trading halt pending news from the FDA.
If Mesoblast gets the green light it would be the first time in US history that a stem cell product like Ryoncil came to market.
In a statement to the ASX, the company has said it intends to enter a halt until an announcement on the FDA’s review, which is now not expected until Monday October 5. It’s currently around 8pm Wednesday on the US east coast and the New York Stock Exchange is closed.
Given the previously outlined schedules, it’s possible the FDA has made its decision.
However, Mesoblast says it intends to stay in a halt until Monday morning, when it expects to be able to share the news
- Forums
- ASX - By Stock
- MSB
- Ann: Trading Halt
Ann: Trading Halt, page-178
-
-
- There are more pages in this discussion • 458 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 75212 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 1.185 |
1 | 20000 | 1.175 |
1 | 5664 | 1.170 |
1 | 17568 | 1.160 |
3 | 56695 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 59712 | 2 |
1.195 | 36255 | 5 |
1.200 | 404381 | 31 |
1.205 | 3000 | 1 |
1.210 | 162475 | 7 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
MSB (ASX) Chart |